A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: whenever (70), consistently (83), always (697)

Apalutamide v1

Description
Chemotherapy Protocol PROSTATE APALUTAMIDE Regimen  Prostate cancer Indication  Apalutamide is recommende
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Apalutamide-v1.pdf

Durvalumab(28day-1500mg)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Durvalumab (28 day – 1500mg) Regimen • NSCLC -
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Durvalumab28day-1500mg.pdf

Vinorelbine (oral day 1 and 8)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Oral) (Day 1 and 8) This protocol may require fundin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineoralday1and8ver11.pdf

Atezolizumab(1680-28days)

Description
Chemotherapy Protocol GENITOURINARY CANCER Atezolizumab (1680mg-28 days) Regimen • Urothelial– Atezolizumab
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab1680-28days.pdf

Tivozanib

Description
Chemotherapy Protocol RENAL CELL Regimen TIVOZANIB • Renal Cell - Tivozanib Indication • Patients with a confirmed his
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Tivozanib.pdf

Sunitinib v1.1

Description
Regimen Renal Cell - Sunitinib Indication Chemotherapy Protocol RENAL CELL SUNITINIB First line treatment of ad
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Sunitinib-v1.1.pdf

Pazopanib v1.1

Description
Chemotherapy Protocol RENAL CELL PAZOPANIB Regimen Renal Cell - Pazopanib Indication F
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Pazopanib-v1.1.pdf

Cabozantinib

Description
Chemotherapy Protocol RENAL CELL CANCER Regimen CABOZANTINIB • Renal Cell – Cabozantinib (60mg-tablet
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Cabozantinib.pdf

Axitinib v1.2

Description
Chemotherapy Protocol RENAL CELL AXITINIB This regimen may require funding Regimen Renal Cell - Axitinib Indica
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Axitinib-v1.2.pdf

Audit and Risk Committee ToR Jan 2022

Description
Audit and Risk Committee Terms of Reference Date Issued: 27 January 2022 Review Date: January 2023 Document Type: Commi
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Audit-and-Risk-Committee-ToR-Jan-2022.pdf
731 to 740 of 768
Previous … 72 73 74 75 76 … Next